The U.S. stock market has its own Island of Misfit Toys. When you look at the lower tiers of the market right now, the sheer desperation for a buzzy narrative is staggering. We have crypto miners pretending to be AI visionaries, and financial printers pivoting to TikTok influencers. This is stupid and here's why: you can't meme a business model into existence. Let's see who is actually making money and who is just throwing buzzwords at the wall.

Digi Power X (DGXX.US) wants us to believe they are no longer just a crypto miner, but a Tier III AI infrastructure platform buying NVIDIA B200 GPUs. In Q2 2026, their total revenue was USD 6.63M, down 18%, while net loss expanded 38% to USD 14.4M. The CEO is buying shares on the open market, but good luck convincing Wall Street you are the next CoreWeave when your core business is bleeding.

Then there is Rich Sparkle (ANPA.US). A traditional financial printer goes public on Nasdaq and suddenly announces the acquisition of TikTok star Khaby Lame's core company in January 2026, alongside a bizarre USD 50M EDU token strategy. Their net loss recently widened 70%. This feels like a desperate pivot masquerading as a strategy.

707 Cayman Holdings (JEM.US) is another one. They just implemented a 12-for-1 reverse split in July 2026, barely a month after their IPO, just to maintain compliance. Now they are exploring an "AI-driven blockchain supply chain platform." Why aren't you focusing on your actual clothing business instead of buzzword bingo?

Meanwhile, Profire Energy (PFIE.US) shows what happens when you build a real business. They posted record Q3 2024 revenue of USD 17.2M, and now CECO Environmental is acquiring them for USD 125M. This is what a real exit looks like—no blockchain needed.

The rest of the group is a strange mix. Ryan Specialty (RYAN.US) quietly raked in USD 916.6M in Q2 2026 revenue, up 9%. It's boring insurance brokerage, but it works. BNY Mellon (BNY.US) sits here like an adult in a daycare, casually beating Q2 2026 estimates with USD 5.7B in revenue. They manage USD 59.3T in assets and just added OpenAI's board members to their ranks.

On the biotech and real estate fronts, Crescent Biopharma (CBIO.US) is playing the classic clinical-stage survival game, posting an in-line Q2 2026 loss while raising more cash. Alset Inc. (AEI.US) is still pushing its sustainable EHome communities narrative while trading deep in penny stock territory.

Finally, Wall Street continues its relentless financialization of crypto. BlackRock just launched the iShares Bitcoin Premium Income ETF (BITA.US) in June 2026 to milk yield chasers, while the IDX Alternative FIAT ETF (GLDB.US) is awkwardly mashing Gold and Bitcoin together. And if you remember the old Chinese auto site Bitauto (which previously traded as BITA before its 2020 privatization), you know that sometimes leaving the public market entirely is the smartest move you can make.

This article does not constitute investment advice.